Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Higher Today

Activist investor Elliott Investment Management has taken a significant position in BioMarin Pharmaceutical Inc BMRN, engaging with the company on its strategic direction amid leadership changes and the evolving status of its hemophilia treatment, Roctavian. The hedge fund has invested over $1…#activist #bmrn #hemophilia #biomarin #roctavian #isharesbiotechnology #ibb #medicare #jeanjacquesbienaime #alexanderhardy
Source: Reuters: Health - Category: Consumer Health News Source Type: news